The Global Cardiovascular Diagnostics Industry is on a trajectory of unprecedented growth, forecasted to surge from US$ 5.6 Billion in 2022 to a staggering US$ 9.7 Billion by the conclusion of 2033. This remarkable expansion, projected at a robust Compound Annual Growth Rate (CAGR) of 5.1% over the forecast period (2023 to 2033), underscores the burgeoning significance of cardiovascular health on a global scale.
A confluence of factors is fueling this substantial market growth, chief among them being the escalating prevalence of cardiovascular diseases (CVD) worldwide. As tobacco consumption continues to rise across the globe, the incidence of cardiovascular disorders has followed suit, necessitating advanced diagnostic solutions to combat this pervasive health challenge.
Request a Sample of this Report Now!
https://www.futuremarketinsights.com/reports/sample/rep-gb-17465
By developing new imaging technologies, portable diagnostic gadgets, and molecular diagnostic techniques, manufacturers can innovate and improve patient care. Furthermore, the use of data analytics and AI algorithms improves diagnostic accuracy and clinical decision-making. However, problems such as a shortage of skilled staff, budgetary constraints, and insufficient regulations and policies are limiting market expansion.
The market experienced growth in 2021, surpassing initial projections before the COVID-19 pandemic. Since the emergence of COVID-19 three years ago, over 750 million individuals worldwide have been affected by the disease. Recent studies have indicated that certain individuals who have contracted COVID-19 are at a higher risk of developing cardiovascular conditions like irregular heartbeat, stroke, and heart failure.
The connection between COVID-19 and cardiovascular disease has been observed, highlighting the potential long-term impact of the virus on cardiovascular health. This correlation emphasizes the importance of addressing and monitoring the cardiovascular health of individuals who have had COVID-19, as well as the need for continued research and advancements in cardiovascular diagnostics and treatments to mitigate the potential consequences of the disease. Overall, the cardiovascular diagnostic market is likely to expand in the next years, offering a cost-effective and simple option for patients suffering from CVDs.
Key Takeaways from this Global Cardiovascular Diagnostics Industry:
- Electrocardiogram (ECG) systems hold a significant market share of 43.4% in the global cardiovascular diagnostics market in 2022 due to the prominence of ECG systems globally.
- Hospitals take away the larger share among all end users due to the availability of most diagnostic products and equipment in the hospitals. The segment held around 30.5% value share in 2022.
- The North American region accounts for the dominant market share at 37.4%, with a market value of US$ 2.1 Billion in 2022 owed to the strong market presence of key players in North America contributing to the overall advancement and expansion of the cardiovascular diagnostics market.
“The increasing global prevalence of the cardiovascular disease has led to a growing demand for CVD diagnostics in recent years, this presents a favourable opportunity for entry into the cardiovascular disease diagnostic market,” – says an analyst at Future Market Insights (FMI).
Ask Us Your Questions About This Report
https://www.futuremarketinsights.com/ask-question/rep-gb-17465
Global Cardiovascular Diagnostics Industry Competition:
The cardiovascular diagnostic industry is extremely competitive, with GE Healthcare and Abbott Laboratories among the leading participants. To achieve a greater market share, these firms are continually reinventing their goods and marketing techniques, with an emphasis on price, convenience, and efficacy.
- In February 2023, GE HealthCare aims to revolutionize ultrasounds by making them accessible worldwide, as demonstrated by their recent acquisition of Caption Health, an AI software company specializing in cardiac imaging.
- In September 2022, SRL Diagnostics introduces ‘Heart Assure’, a specialized blood test using high-sensitivity Troponin I to accurately predict the risk of cardiac events.
What Does This Report Cover?
Future Market Insights offers a unique perspective and actionable insights on the cardiovascular diagnostic market in its latest study, presenting a historical demand assessment of 2017– 2022 and projections for 2023 – 2033. The cardiovascular diagnostic market is segmented in detail to cover every aspect of the market and present a complete market intelligence approach to the reader.
The research study is based on the Electrocardiogram (EEG) systems (resting ECG systems, cardiopulmonary stress testing systems), Holter monitoring devices, Event monitoring devices (Implantable Loop Recorder (ILR), others) and point of care testing (Analyzers lipoprotein test kits, angiotensin test kits, fibrinogen test kits, serum uric acid test kits, high-sensitivity CRP (hs-CRP) kit), across 7 key regions of the world.
Global Cardiovascular Diagnostics Industry Key Players:
- Medtronic plc
- Abbott Laboratories
- Boston Scientific Corporation
- Biotronik SE & Co. KG
- Schiller, Koninklijke Philips N.V.
- GE Healthcare and Wayra
- Siemens Healthcare
- Lepu Medical
- Midmark Corp
- Roche Ltd
- Randox Laboratories Ltd.
- Robotnik India
- Diasorin
- Elabscience Biotechnology
Click Here To Buy Your Full Report
https://www.futuremarketinsights.com/checkout/17465
Key Segmentation from the Global Cardiovascular Diagnostics Industry:
By Product:
- Electrocardiogram (ECG) system
- Resting ECG Systems
- Cardiopulmonary Stress Testing Systems
- Holter Monitoring Devices
- Event Monitoring Devices
- Implantable Loop Recorder (ILR)
- Others
By Point-of-Care Testing:
- Analyzers
- Lipoprotein Test Kits
- Angiotensin Test Kits
- Fibrinogen Test Kits
- Serum Uric Acid Test Kits
- High-Sensitivity CRP (hs-CRP) Kits
By End User:
- Hospitals
- Ambulatory Surgical Centers
- Specialty Clinics
- Cardiac Catheterization Labs
- Diagnostic Imaging Centers
About Future Market Insights (FMI)
Future Market Insights, Inc. (ESOMAR certified, Stevie Award – recipient market research organization and a member of Greater New York Chamber of Commerce) provides in-depth insights into governing factors elevating the demand in the market. It discloses opportunities that will favor the market growth in various segments on the basis of Source, Application, Sales Channel and End Use over the next 10-years.
Contact Us:
Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-845-579-5705
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube